SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                                 SCHEDULE 13D
                                (Rule 13d-101)

            INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
           TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
                                 RULE 13d-2(a)

                              (Amendment No. 6 )(1)

                           Appiant Technologies, Inc.
                      (f/k/a Nhancement Technologies, Inc.)
--------------------------------------------------------------------------------
                                (Name of Issuer)


                          Common Stock, $.01 par value
--------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    03782R108
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                               Gerald L. Fishman
                               Wolin & Rosen, Ltd.
                        55 West Monroe Street, Suite 3600
                                Chicago, IL 60603
                                  312.424.0600
--------------------------------------------------------------------------------
                 (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications)

                                 July 31, 2000
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of This Statement)

     If the filing  person has  previously  filed a statement on Schedule 13G to
report the  acquisition  that is the subject of this Schedule 13D, and is filing
this  schedule  because  of Rule  13d-1(e),  13d-1(f)  or  13d-1(g),  check  the
following box [_].


          Note:  Schedules filed in paper format shall include a signed original
     and five copies of the schedule,  including all exhibits. See Rule 13d-7(b)
     for other parties to whom copies are to be sent.

-------------------------------------------------
(1)  The  remainder  of this  cover  page  shall be filled  out for a  reporting
     person's  initial  filing on this form with respect to the subject class of
     securities,  and for any subsequent amendment containing  information which
     would alter disclosures provided in a prior cover page.

     The  information  required on the remainder of this cover page shall not be
     deemed to be  "filed"  for the  purpose  of  Section  18 of the  Securities
     Exchange  Act of 1934  or  otherwise  subject  to the  liabilities  of that
     section of the Act but shall be subject to all other  provisions of the Act
     (however, see the Notes).

(SC13D-07/99)
                         (Continued on following pages)
                              (Page 1 of 7 Pages)


CUSIP No.   03782R108                  13D                   Page  2 of 7 Pages


________________________________________________________________________________
1    NAME OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

L. Thomas Baldwin III                                       SS No.
L. Thomas Baldwin III Living Trust u/t/a dated 11/9/95    FEIN No.
________________________________________________________________________________
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)  [X]
                                                                 (b)  [_]
     See Note A
________________________________________________________________________________
3    SEC USE ONLY


________________________________________________________________________________
4    SOURCE OF FUNDS*

     PF -- See Note A

________________________________________________________________________________
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)
                                                           Item 2(d) [_]
                                                           Item 2(e) [_]
________________________________________________________________________________
6    CITIZENSHIP OR PLACE OF ORGANIZATION

     Illinois
________________________________________________________________________________
               7    SOLE VOTING POWER

  NUMBER OF         3,237,675   See Note A

   SHARES      _________________________________________________________________
               8    SHARED VOTING POWER
BENEFICIALLY
                      586,490   See Note A
  OWNED BY
               _________________________________________________________________
    EACH       9    SOLE DISPOSITIVE POWER

  REPORTING          3,237,675  See Note A

   PERSON      _________________________________________________________________
               10   SHARED DISPOSITIVE POWER
    WITH
                       586,490  See Note A





CUSIP No.   03782R108                  13D                   Page  3 of 7 Pages


________________________________________________________________________________
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

             3,086,245 -- L. Thomas Baldwin III  (See Note A)
               151,430 -- L. Thomas Baldwin III Living Trust  (See Note A)
________________________________________________________________________________
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

                      [X]
     See Note A
________________________________________________________________________________
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     25.2%

________________________________________________________________________________
14   TYPE OF REPORTING PERSON*

     IN -- L. Thomas Baldwin III
     OO -- L. Thomas Baldwin III Living Trust

________________________________________________________________________________
                     *SEE INSTRUCTIONS BEFORE FILLING OUT!



ITEM 1.  SECURITY AND ISSUER

         a.       Appiant Technologies, Inc.
                  (f/k/a Nhancement Technologies, Inc.)
                  6663 Owens Drive
                  Pleasanton, CA    94588

         b.       Common Stock, $.01 par value

ITEM 2.  IDENTITY AND BACKGROUND

a.  L. Thomas Baldwin III             a.   L. Thomas Baldwin III Living
                                           Trust, L. Thomas Baldwin III, Trustee

b.  141 West Jackson Boulevard        b.   141 West Jackson Boulevard
    Suite 2850                             Suite 2850
    Chicago, IL    60604                   Chicago, IL    60604

c.  Investor, Trader                  c.   Trust, Trustee

d.  N/A                               d.   N/A

e.  N/A                               e.   N/A

f.  USA                               f.   Illinois, USA


ITEM 3.  SOURCE AND AMOUNT OF FUNDS FOR OTHER CONSIDERATION

     The source of the funds are the personal funds of L. Thomas Baldwin III and
the L. Thomas  Baldwin III Living Trust.  The aggregate  amount of funds used in
making purchases through and including 31 March 2001 for these Reporting Persons
(see Note A) were  $49,962,198  for Mr. Baldwin and $2,645,036 for the L. Thomas
Baldwin III Living Trust.




CUSIP No.   03782R108                  13D                   Page  4 of 7 Pages


ITEM 4.  PURPOSE OF TRANSACTION


          The purpose of the  acquisition of securities of the Issuer is as an
     investment by L. Thomas Baldwin III.


     a.   Mr. Baldwin has no present plans to purchase  additional shares of the
          Issuer  except as a result  of  possible  conversion  or  exercise  of
          convertible securities or warrants currently held by him.

     b-j. Mr. Baldwin has no present intentions to engage in or cause any of the
          matters  listed  in these  subsections  of this  Item 4.  His  present
          intention is to be and remain an investor in the Issuer.  In December,
          2000, Mr. Baldwin was elected a director of the Issuer. The timing and
          amount of additional purchases, if any, are currently unknown.

ITEM 5.  INTEREST AND SECURITIES OF THE ISSUER

         a.       Shares owned:

                  (1)     L. Thomas Baldwin III -- 3,237,675 shares (25.2%)
                          (See Note A)

                  (2)     Rosenthal Collins Group, L.L.C.  (See Note A)

                          (i)  L. Thomas Baldwin III -- 435,060 shares (3.4%)

                          (ii) L. Thomas  Baldwin III Living  Trust -- 151,430
                               shares(1.2%)

                          Total Rosenthal Collins Group, L.L.C.  --  586,490
                          shares (4.6%)

                  Total Group (See Note A) -- 3,824,165 shares (29.8%)

         b.       Voting power:

                  (1)      L. Thomas Baldwin III, individually (See Note A)
                           Sole voting  power --  3,237,675
                           Shared  voting power ---  586,490
                           Sole dispositive  power --  3,237,675
                           Shared  dispositive power --   586,490

                  (2)      Rosenthal Collins Group, L.L.C. (See Note A)
                           Sole voting power -- 586,490
                           Shared voting power  ---  586,490
                           Sole dispositive power  --  586,490
                           Shared dispositive power  --  586,490




CUSIP No.   03782R108                  13D                   Page  5 of 7 Pages




     c.   In connection with its $2,500,000  Convertible  Promissory Note issued
          to this  Reporting  Person,  the Issuer agreed to issue this Reporting
          Person a Warrant to purchase  462,963  shares of the  Issuer's  Common
          Stock,  subject  to  adjustment  and to  the  issuance  of  additional
          Warrants  if the Issuer  does not receive  certain  additional  equity
          investments.  All such  Warrants  are  exercisable  immediately  at an
          exercise price of $2.70 per share  (subject to adjustment  pursuant to
          the terms of the Warrants) and expire 7 years from issuance.

          On May 31 2001, this Reporting  Person  purchased at par, the Issuer's
          $150,000 face amount Convertible  Promissory Note ("Promissory  Note")
          due and payable on June 21,  2001,  ("Maturity  Date").  The number of
          shares into which the Promissory Note may be converted on the Maturity
          Date is equal to the amount due under the Promissory Note divided by a
          conversion   price  determined  by  taking  90%  of  the  exercise  or
          conversion  price (or  exchange  factor)  applicable  to any  security
          comprising any  interim  financing  subsequent  to the  date  of the
          Promissory  Note  ("Interim   Financing")   which  is  exercisable  or
          convertible  into or  exchangeable  for the Issuer's  Common Stock. If
          there is no Interim  Financing  on or before the Maturity  Date,  then
          this  Reporting  Person may choose to convert  the amount due from the
          Issuer into shares at 90% of the closing price of the Issuer's  Common
          Stock on the trading day immediately preceding the Maturity Date.

          In further  consideration  for the  Promissory  Note,  this  Reporting
          Person is to  receive  a  warrant  to  purchase  30,000  shares of the
          Issuer's Common Stock, exercisable  immediately,  at an exercise price
          of $1.57 per  share.  The Issuer  has  agreed to  register  the shares
          issuable upon exercise in its next registration of shares.

     d.       N/A

     e.       N/A


ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
         TO SECURITIES OF THE ISSUER

          See Note A with respect to the  relationships  among the persons named
          in Item 2 and with respect to the securities of the Issuer.

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS

         1.       There  are no materials relating to the borrowing  of funds to
                  finance the acquisition, as disclosed in Item 3.



CUSIP No.   03782R108                  13D                   Page  6 of 7 Pages


         2.       There are no written agreements relating to the acquisition of
                  Issuer control,  liquidation, sale of assets, merger or change
                  in business or  corporate  structure or any other  matter,  as
                  disclosed in Item 4.

         3.       There are no written  agreements  relating to the  transfer of
                  voting  of the  securities,  finders'  fees,  joint  ventures,
                  options, puts, calls,  guarantees of loans, guarantees against
                  loss of profit,  or the giving or withholding of any proxy, as
                  disclosed in Item 6, except the Common Stock Warrant attached
                  as an Exhibit hereto.

SIGNATURE

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

Date:  June 22, 2001.

                                            /s/  L. Thomas Baldwin III
                                            ------------------------------------
                                            L. THOMAS  BALDWIN  III,
                                            Individually  and as Trustee of
                                            the L. Thomas  Baldwin III Living
                                            Trust u/t/a dated 11/9/95


Attention.  Intentional  misstatements  or omissions of fact constitute  federal
criminal violations (see 18 U.S.C. 1001).


                                     NOTE A

This Schedule 13D represents ownership by the Reporting Person and other members
of the "group" as described below of an aggregate of 3,824,165  shares of common
stock of the Issuer  (29.8%),  including  immediately  exercisable  warrants  to
purchase 300,000 shares at $6.00 per share and 30,000 shares at $1.57 per share,
but excluding (i) shares  issuable upon  conversion of a $2,500,000  Convertible
Promissory  Note and a Warrant to purchase  462,963  shares (as may be adjusted)
(not more than 19.9% without shareholder approval) and (ii) shares issuable upon
conversion of a $150,000  Convertible  Promissory Note, all as described in Item
5c  above.  L.  Thomas  Baldwin  III is a  non-voting,  non-managing  member  of
Rosenthal Collins Group,  L.L.C., an Illinois limited liability company ("RCG").
RCG is registered  with the Commodity  Futures  Trading  Commission as a futures
commission  merchant  and is a clearing  member of all major  principal  futures
exchanges in the United States and  elsewhere.  As such, RCG is required to meet
and maintain  significant levels of adjusted net capital to comply with CFTC and
exchange clearing requirements.

While RCG has full legal control over 586,490  shares,  Mr. Baldwin could always
direct  RCG to sell the  shares,  which  accommodation  RCG would be  willing to
accommodate  subject,  of course,  to all the various capital  requirements with
which RCG must comply.  Moreover,  as an accommodation,  RCG would be willing to
defer to Mr.  Baldwin with respect to the voting of such shares.  Hence,  RCG in
Item 5.b has  listed  the  shares  deposited  with it as owned by it, and it has
listed voting and dispositive power as shared with Mr. Baldwin.




CUSIP No.   03782R108                  13D                   Page  7 of 7 Pages

While the shares of the Issuer held by RCG are owned of record and are under its
total legal  control,  RCG,  solely for purposes of the shares of the Issuer and
not  otherwise,  should be deemed an affiliate of L. Thomas  Baldwin III and Mr.
Baldwin  should  be  deemed  de  facto  beneficial  owner  of all  such  shares,
notwithstanding  that all such shares are subject to the risks and requirements,
regulatory and market, of RCG.